Intracerebral Hemorrhage Clinical Trial
Official title:
The Research of Etiology and Risk Factors Related to Prognosis of Intracerebral Hemorrhage in Beijing
There were lack of data and analysis about medical management, etiology, and long-term outcome of Intracerebral Hemorrhage (ICH) in Beijing. In this study the investigators do acute CT angiography, a non-invasive imaging method to explore etiology and prognostic risk factors of ICH. Further the investigators will aim to develop and validate a risk score for predicting 1-year functional outcome after ICH.
Intracerebral hemorrhage (ICH) accounts for 10 %-15 % of all strokes and is one of leading
causes of stroke related mortality and morbidity worldwide. Despite advances in medical
knowledge, treatment for ICH remains strictly supportive. ICH accounted for 26.7~51.5% of
stroke in China, the proportion was higher than in Western countries. There were lack of
data and analysis about medical management, etiology, and long-term outcome of ICH in
Beijing.
In this study we do acute CT angiography (CTA), a non-invasive imaging method to explore
etiology and prognostic risk factors of ICH. Further we will aim to develop and validate a
risk score for predicting 1-year functional outcome after ICH. There are some studies of CTA
to assess the cause of ICH and functional outcomes, but lack of multi-center, large sample
studies to support and validate these findings, particularly fewer application of
postcontrast CT. This would allow an early intervention base on different causes and Select
treatment decisions according to risk score.
We are planning to:
When patients with ICH arrive in stroke department of the topic cooperation hospitals within
72 hours after symptom onset, they will be subject to CTA with the protocoled sequences.
Standard sequences: Pre- and postcontrast head imaging is acquired from the skull base to
vertex with parameters: 120 kVp; 340 mA; 4x5 mm collimation; 1second/rotation; and a table
speed of 15 mm/rotation. CTA was performed immediately after initial noncontrast CT(NCCT)
performance using a bolus-tracking method by injecting 90 mL of nonionic iodinated contrast
(OPTIRAY 350) at 5 mL/s. The protocol for the circle of Willis was 120 kVp, 360 mAs, 0.5
second/rotation, 0.75 mm thick with a pitch of 0.65. Postprocessing procedure including
multiplanar reconstruction was performed by a CT technologist at the CT operator's
discretion for assessment of contrast extravagation and etiologies of ICH such as vascular
malformation, and venous sinus thrombosis. Coronal and sagittal multiplanar reconstructed
images were created as 10.0-mm-thick images spaced by 3 mm. Axial reformed images were 4 mm
thick with 2-mm spacing.
Clinical data of patients with ICH will be collected by 2 neurologists blinded to the
radiological data during patients' hospitalization and at the 3-month, 6-month, and 1-year
follow-up. The collected demographic and clinical variables included gender, age, body mass
index, alcohol and tobacco use, history of hypertension, diabetes, hyperlipidemia, stroke,
coronary heart disease, and medications (antihypertensive, antiplatelet, and anticoagulation
agents). The systolic and diastolic blood pressure of patients will be recorded. Stroke
severity on admission will be evaluated by Glasgow Coma Scale and National Institutes of
Health Stroke Scale. Laboratory tests on admission included white blood cell count,
hemoglobin, platelet count, serum glucose, serum creatinine, fibrinogen, activated partial
thromboplastin time, and prothrombin time as expressed by the international normalized
ratio. Length of hospital stay was recorded. The patients' clinical outcome will be assessed
by modified Rankin Scale on discharge and 30-day, 3-month, 6-month, and 1-year.
To sum up the purpose of this present study is to explore etiology and prognostic risk
factors of ICH by acute CTA and develop and validate a risk score for predicting 1-year
functional outcome after ICH.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05089331 -
ROSE-Longitudinal Assessment With Neuroimaging
|
||
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Active, not recruiting |
NCT04522102 -
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe (ASPIRING)-Pilot Phase
|
Phase 3 | |
Terminated |
NCT04178746 -
PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
|
||
Not yet recruiting |
NCT03956485 -
Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
|
||
Enrolling by invitation |
NCT02920645 -
Multicenter Validation of the AVICH Score
|
N/A | |
Recruiting |
NCT02625948 -
Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign
|
Phase 2 | |
Completed |
NCT02478177 -
Addressing Real-world Anticoagulant Management Issues in Stroke
|
||
Completed |
NCT01971359 -
Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study
|
N/A | |
Completed |
NCT01261091 -
Early Tracheostomy in Ventilated Stroke Patients
|
N/A | |
Terminated |
NCT00990509 -
Albumin for Intracerebral Hemorrhage Intervention
|
Phase 2 | |
Completed |
NCT00716079 -
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial
|
N/A | |
Recruiting |
NCT00222625 -
rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
|
Phase 2 | |
Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
Recruiting |
NCT04548596 -
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
|
||
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Recruiting |
NCT05492474 -
Cranial Ultrasound for Prehospital ICH Diagnosis
|
N/A | |
Not yet recruiting |
NCT05502874 -
Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage
|
||
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Recruiting |
NCT05504941 -
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
|
N/A |